The board of Cryo-Cell International, Inc. (NYSEAM:CCEL) announced the Spin-Off of Celle Corp. to its shareholders on March 25, 2024. The board of Directors of Cryo-Cell International has authorized the spin-off of its newly formed subsidiary, Celle Corp., to the Cryo-Cell shareholders currently anticipated to be in the form of a stock dividend to the Cryo-Cell shareholders and to occur in Cryo-Cell?s 2nd or 3rd fiscal quarters.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.2 USD | +0.22% | +1.43% | +60.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.00% | 74.4M | |
+20.12% | 83.46B | |
-2.68% | 25.66B | |
+3.31% | 17.91B | |
-15.31% | 16.54B | |
+0.22% | 15.43B | |
+75.22% | 13.46B | |
+74.08% | 12.78B | |
+40.02% | 12.6B | |
+1.03% | 12.55B |
- Stock Market
- Equities
- CCEL Stock
- News Cryo-Cell International, Inc.
- Cryo-Cell International, Inc. agreed to Spin-Off Celle Corp.